Ads
related to: full non invasive liver screen test results range- Management Information
Discover More Information
On The Patient Site.
- Downloadable Resources
Download Doctor Discussion Guide
And Other Helpful Patient Resources
- Patient Ambassador
Register for an event & learn more
from a Nurse Educator.
- Tools And Support
Get Helpful Resources And
Support For Patients.
- Specialist Finder
Search for providers specializing
in management options.
- Stay Informed
Sign Up For Updates
And Get Helpful Information.
- Management Information
Search results
Results From The WOW.Com Content Network
FibroTest, known as FibroSure in the US, is a biomarker test that uses the results of six blood serum tests to generate a score that is correlated with the degree of liver damage in people with a variety of liver diseases. FibroTest has the same prognostic value as a liver biopsy.
FibroTest (FibroSure in the USA) and FibroMax are non-invasive tests using a blood sample and an algorithm. The test results correspond to stages F0-F4 and grades A0-A3 of the METAVIR scoring system. [20] In 2007 FibroTest was validated by French Health Authorities as a first-line diagnosis of liver injury before biopsy.
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. [1] These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin , bilirubin (direct and indirect), and others.
Reference ranges (reference intervals) for blood tests are sets of values used by a health professional to interpret a set of medical test results from blood samples. Reference ranges for blood tests are studied within the field of clinical chemistry (also known as "clinical biochemistry", "chemical pathology" or "pure blood chemistry"), the ...
This page was last edited on 27 November 2016, at 01:20 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The NICE advises regular screening of NAFLD for advanced liver fibrosis every three years to adults and every two years for children using the enhanced liver fibrosis (ELF) blood test. [66] Follow-up is recommended for people with obesity and insulin resistance using the homeostasis model assessment of insulin resistance (HOMA-IR).
Ads
related to: full non invasive liver screen test results range